Literature DB >> 31461699

Mechanisms of Stroke in Patients with Chronic Kidney Disease.

Shivani Ghoshal1, Barry I Freedman2.   

Abstract

BACKGROUND: Given the increasing worldwide prevalence of chronic kidney disease (CKD), it is critical to decrease the associated risk of debilitating vascular complications, including stroke, congestive heart failure, myocardial infarction, and peripheral vascular disease. Treatment options for reducing the risk of all subtypes of stroke in patients with CKD remain limited. For patients with end-stage kidney disease (ESKD), novel applications of noninvasive imaging may help personalize the type of dialysis and dialysis prescription for patients at high-risk.
SUMMARY: This manuscript reviews the heightened risk of stroke in patients with nephropathy, including ischemic and hemorrhagic subtypes. Mechanisms associated with increased risk include alterations in cardiac output, platelet function, regional cerebral perfusion, accelerated systemic atherosclerosis, altered blood brain barrier, and disordered neurovascular coupling. There is great potential for noninvasive monitoring of the cerebral vasculature using transcranial Doppler (TCD) to reduce stroke risk, particularly in patients with ESKD. Key Messages: Compared to the general population, patients with CKD are at heightened risk for all subtypes of stroke. This is due to a multitude of mechanisms linking nephropathy with altered cerebral perfusion, cerebral neurovascular coupling, and blood vessel integrity. Intracranial imaging is not currently standard of care practice in patients with CKD or ESKD. TCD may provide clinicians real-time and noninvasive measurement of brain perfusion. This could be useful for assessing risk of stroke in patients' initiating dialysis, individualizing dialysis prescriptions, and potentially reducing rates of cerebrovascular disease and stroke in high-risk patients.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Arteriosclerosis; Cerebral autoregulation; Cerebral blood flow; Chronic kidney disease; Stroke

Year:  2019        PMID: 31461699     DOI: 10.1159/000502446

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  15 in total

1.  A Dynamic Nomogram to Identify Patients at High Risk of Poor Outcome in Stroke Patients with Chronic Kidney Disease.

Authors:  Fusang Wang; Xiaohan Zheng; Juan Zhang; Fuping Jiang; Nihong Chen; Mengyi Xu; Yuezhang Wu; Junshan Zhou; Xiaoli Cui; Jianjun Zou
Journal:  Clin Interv Aging       Date:  2022-05-10       Impact factor: 4.458

Review 2.  Cerebrovascular Disease, Cardiovascular Disease, and Chronic Kidney Disease: Interplays and Influences.

Authors:  J David Spence; Bradley L Urquhart
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-01       Impact factor: 6.030

3.  Age Modifies Intracranial and Gastrointestinal Bleeding Risk from P2Y12 Inhibitors in Patients Receiving Dialysis.

Authors:  Nishank Jain; Bradley C Martin; Junqiang Dai; Milind A Phadnis; Layth Al-Hindi; Theresa I Shireman; S Susan Hedayati; Rafia S Rasu; Jawahar L Mehta
Journal:  Kidney360       Date:  2022-05-18

Review 4.  The Intersection of SGLT2 Inhibitors, Cognitive Impairment, and CKD.

Authors:  J Ariana Noel; Ingrid Hougen; Manish M Sood
Journal:  Front Neurol       Date:  2022-06-21       Impact factor: 4.086

5.  Disturbed neurovascular coupling in hemodialysis patients.

Authors:  Mei Jin; Liyan Wang; Hao Wang; Xue Han; Zongli Diao; Wang Guo; Zhenghan Yang; Heyu Ding; Zheng Wang; Peng Zhang; Pengfei Zhao; Han Lv; Wenhu Liu; Zhenchang Wang
Journal:  PeerJ       Date:  2020-04-15       Impact factor: 2.984

Review 6.  Cerebral Autoregulation in Ischemic Stroke: From Pathophysiology to Clinical Concepts.

Authors:  Ricardo C Nogueira; Lucy Beishon; Edson Bor-Seng-Shu; Ronney B Panerai; Thompson G Robinson
Journal:  Brain Sci       Date:  2021-04-16

7.  Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.

Authors:  Zien Zhou; Meg J Jardine; Qiang Li; Brendon L Neuen; Christopher P Cannon; Dick de Zeeuw; Robert Edwards; Adeera Levin; Kenneth W Mahaffey; Vlado Perkovic; Bruce Neal; Richard I Lindley
Journal:  Stroke       Date:  2021-04-20       Impact factor: 7.914

Review 8.  Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology.

Authors:  Saeideh Aghayari Sheikh Neshin; Shima Shahjouei; Eric Koza; Isabel Friedenberg; Faezeh Khodadadi; Mirna Sabra; Firas Kobeissy; Saeed Ansari; Georgios Tsivgoulis; Jiang Li; Vida Abedi; Donna M Wolk; Ramin Zand
Journal:  Front Cardiovasc Med       Date:  2021-03-29

Review 9.  Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease.

Authors:  Colleen S Curran; Jeffrey B Kopp
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

10.  Collateral estimation by susceptibility-weighted imaging and prediction of functional outcomes after acute anterior circulation ischemic stroke.

Authors:  Hyung Jin Lee; Hong Gee Roh; Sang Bong Lee; Yoo Sung Jeon; Jeong Jin Park; Taek-Jun Lee; Yu Jin Jung; Jin Woo Choi; Young Il Chun; Hee Jong Ki; Junsoo Cho; Ji Sung Lee; Hyun Jeong Kim
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.